Drugs / MMH-407
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT04250311 | Dec 2019 → Dec 2024 | influenza | Materia Medica Holding | Suspended | No outcome recorded |
| Phase 3 | NCT04244084 | Oct 2019 → Apr 2020 | viral respiratory tract infection | Materia Medica Holding | Completed | Met primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MMH-407 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04250311 ↗ |
| Route | Oral | “Oral use.” NCT04244084 ↗ |